Minerva Surgical (UTRS)
(Delayed Data from OTC)
$0.00 USD
0.00 (0.00%)
Updated May 2, 2024 01:18 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Minerva Surgical, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | NA | 50 | 52 | 38 | NA |
Cost Of Goods | NA | 23 | 22 | 19 | NA |
Gross Profit | NA | 27 | 31 | 19 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 58 | 60 | 35 | 0 |
Income After Depreciation & Amortization | 0 | -31 | -29 | -15 | 0 |
Non-Operating Income | NA | 0 | 19 | 9 | NA |
Interest Expense | NA | 3 | 12 | 12 | NA |
Pretax Income | NA | -34 | -21 | -18 | NA |
Income Taxes | NA | 0 | 0 | 0 | NA |
Minority Interest | NA | 0 | 0 | 0 | NA |
Investment Gains/Losses | NA | 0 | 0 | 0 | NA |
Other Income/Charges | NA | 0 | 0 | 0 | NA |
Income From Cont. Operations | NA | -34 | -21 | -18 | NA |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | NA |
Net Income (GAAP) | NA | -34 | -21 | -18 | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | -20 | -15 | -5 | 0 |
Depreciation & Amortization (Cash Flow) | NA | 11 | 14 | 10 | NA |
Income After Depreciation & Amortization | 0 | -31 | -29 | -15 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | NA | 1.44 | 0.35 | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | -23.60 | -61.20 | NA | NA |
Diluted Net EPS (GAAP) | NA | -23.60 | -61.20 | NA | NA |
Fiscal Year end for Minerva Surgical, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | NA | 11.97 | 13.39 | 12.53 |
Cost Of Goods | NA | NA | 5.75 | 5.99 | 5.52 |
Gross Profit | NA | NA | 6.22 | 7.40 | 7.02 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 12.31 | 15.06 | 17.33 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | -6.09 | -7.66 | -10.31 |
Non-Operating Income | NA | NA | 0.09 | 0.15 | 0.04 |
Interest Expense | NA | NA | 1.17 | 1.13 | 1.07 |
Pretax Income | NA | NA | -7.18 | -8.64 | -11.34 |
Income Taxes | NA | NA | 0.00 | 0.04 | 0.00 |
Minority Interest | NA | NA | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | NA | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | NA | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | NA | -7.18 | -8.68 | -11.34 |
Extras & Discontinued Operations | NA | NA | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | NA | -7.18 | -8.68 | -11.34 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | 8.87 | 8.85 | 4.78 |
Diluted EPS Before Non-Recurring Items | NA | NA | -0.81 | -1.00 | -2.40 |
Diluted Net EPS (GAAP) | NA | NA | -0.81 | -1.00 | -2.40 |